Glaucoma Panel
Use
This test is for individuals who have a clinical or suspected diagnosis of glaucoma, as well as those with congenital, pediatric, or adult-onset glaucoma. It is designed to identify variants in 24 genes associated with glaucoma, helping in the confirmation of a clinical diagnosis and guiding management and treatment decisions.
Special Instructions
This test is performed on the Exome or Genome platform, allowing the detection of CNVs. New York state approved. STAT testing available which delivers results faster than routine processing, specifically within 7 to 16 days for STAT orders. Results will be provided via PreventionGenetics' secure web portal, myPrevent, unless specified otherwise.
Limitations
The test has not been cleared or approved by the US Food and Drug Administration. It is important that the test be ordered by a qualified healthcare provider, who should interpret the results in the context of detailed clinical information such as clinical notes, pedigree, and family medical history.
New York Approved
Methodology
NGS
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided